Sera Prognostics Inc.

4.06
-0.08 (-1.93%)
At close: Mar 25, 2025, 3:59 PM
3.97
-2.26%
After-hours: Mar 25, 2025, 05:49 PM EDT
-1.93%
Bid 3.7
Market Cap 148.98M
Revenue (ttm) 77.26K
Net Income (ttm) -33.01M
EPS (ttm) -0.99
PE Ratio (ttm) -4.1
Forward PE -6.17
Analyst n/a
Ask 4.3
Volume 36,037
Avg. Volume (20D) 131,279
Open 4.17
Previous Close 4.14
Day's Range 3.97 - 4.10
52-Week Range 3.77 - 12.36
Beta 0.90

About SERA

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, g...

Sector Healthcare
IPO Date Jul 15, 2021
Employees 63
Stock Exchange NASDAQ
Ticker Symbol SERA
Full Company Profile

Earnings Surprise

Sera Prognostics has released their quartely earnings on Mar 19, 2025:
  • Revenue of $24K misses estimates by $6K, with -41.46% YoY decline.
  • EPS of -0.25 misses estimates by -0.02, with 0.00% YoY growth.
  • Next Earnings Release

    Sera Prognostics Inc. is scheduled to release its earnings on May 7, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -9.44%
    Sera Prognostics shares are trading lower after th... Unlock content with Pro Subscription